Wedbush Starts Cerulean Pharma (CERU) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Leerink Swann Starts Cerulean Pharma (CERU) at Outperform
May 6, 2014 9:11 AM EDTLeerink Swann initiated coverage on Cerulean Pharma (NASDAQ: CERU) with an Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $6.75 yesterday.
... MoreJMP Securities Starts Cerulean Pharma (CERU) at Market Outperform
May 6, 2014 6:38 AM EDTJMP Securities initiated coverage on Cerulean Pharma (NASDAQ: CERU) with a Market Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $6.75 yesterday.
... MoreCanaccord Genuity Starts Cerulean Pharma (CERU) at Buy
May 6, 2014 6:37 AM EDTCanaccord Genuity initiates coverage on Cerulean Pharma (NASDAQ: CERU) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $6.75 yesterday.
... More